Yoshinori Ino Selected Research

Yoshinori Ino Research Topics

Disease

29	Neoplasms (Cancer) 01/2021 - 01/2002
11	Adenocarcinoma 01/2021 - 08/2002
11	Neoplasm Metastasis (Metastasis) 12/2016 - 01/2002
6	Colorectal Neoplasms (Colorectal Cancer) 11/2021 - 01/2005
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2013
4	Carcinoma (Carcinomatosis) 01/2021 - 05/2003
2	Ovarian Neoplasms (Ovarian Cancer) 08/2021 - 01/2021
2	Chronic Pancreatitis 10/2020 - 04/2019
2	Carcinogenesis 01/2019 - 03/2003
2	Stomach Neoplasms (Stomach Cancer) 06/2005 - 04/2004
2	Breast Neoplasms (Breast Cancer) 01/2005 - 09/2002
1	Cholangiocarcinoma 11/2021
1	Neoplasms, Cystic, Mucinous, and Serous 11/2021
1	Bullous Pemphigoid (Pemphigoid) 02/2021
1	Squamous Cell Carcinoma of Head and Neck 02/2021
1	Pharyngeal Neoplasms 02/2021
1	Thymus Neoplasms (Thymus Neoplasm) 06/2020
1	Thymoma (Thymic Carcinoma) 06/2020
1	Primitive Neuroectodermal Tumors (PNET) 10/2017
1	Necrosis 12/2016
1	Gallbladder Neoplasms (Gallbladder Cancer) 12/2015
1	Prostatic Neoplasms (Prostate Cancer) 01/2013
1	Hypoxia (Hypoxemia) 01/2013
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2004
1	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 07/2004
1	Esophageal Squamous Cell Carcinoma 01/2004
1	Thyroid Neoplasms (Thyroid Cancer) 09/2003
1	Papillary Carcinoma 09/2003
1	Adenoma (Adenomas) 03/2003
1	Intestinal Polyps 03/2003

Drug/Important Bio-Agent (IBA)

11	Cadherins (E-Cadherin)IBA 09/2009 - 01/2002
7	Proteins (Proteins, Gene)FDA Link 11/2021 - 03/2003
6	Biological ProductsIBA 01/2020 - 03/2003
5	Glycoproteins (Glycoprotein)IBA 04/2005 - 01/2002
3	LigandsIBA 06/2020 - 01/2011
3	Peptides (Polypeptides)IBA 10/2017 - 07/2004
3	beta CateninIBA 09/2009 - 03/2003
3	CateninsIBA 10/2005 - 07/2002
2	EnzymesIBA 11/2021 - 01/2020
2	polysulfideIBA 08/2021 - 01/2021
2	AntigensIBA 02/2021 - 08/2020
2	Amino Acids FDA Link 01/2019 - 07/2004
2	Indicators and Reagents (Reagents)IBA 01/2013 - 01/2005
2	Biomarkers (Surrogate Marker)IBA 03/2011 - 01/2005
2	Monoclonal AntibodiesIBA 04/2005 - 05/2003
2	Galectin 3 (LGALS3)IBA 05/2003 - 08/2002
1	Ephrin-A5 (AL-1)IBA 01/2022
1	CollagenIBA 01/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2022
1	Aquaporin 1IBA 11/2021
1	UDP-GlcNAc GalNAc-peptide beta1,3-N-acetylglucosaminyltransferaseIBA 11/2021
1	sulfur-32IBA 01/2021
1	monobromobimaneIBA 01/2021
1	Ambroxol (Mucosolvan)IBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	CystathionineIBA 01/2021
1	Expectorants (Mucolytics)IBA 01/2021
1	LyasesIBA 01/2021
1	PlatinumIBA 01/2021
1	SulfurIBA 01/2021
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 10/2020
1	embelinIBA 10/2020
1	E-SelectinIBA 10/2020
1	HLA-G Antigens (HLA G)IBA 08/2020
1	Histocompatibility Antigens Class IIBA 08/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 08/2020
1	Interleukin-13 Receptor alpha2 SubunitIBA 05/2020
1	Polysaccharides (Glycans)IBA 01/2020
1	MucinsIBA 01/2020
1	LectinsIBA 01/2020
1	GAP-43 Protein (GAP 43 Protein)IBA 04/2019
1	SurvivinIBA 10/2017
1	Oncogene Protein v-cblIBA 12/2015
1	Carbonic Anhydrase IXIBA 01/2013
1	OrnithineIBA 01/2013
1	Arginine (L-Arginine)FDA Link 01/2013
1	ArginaseIBA 01/2013
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2012
1	Small Interfering RNA (siRNA)IBA 01/2012
1	Complement C9 (Complement Component 9)IBA 03/2011
1	Blood Proteins (Serum Proteins)IBA 03/2011
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 03/2011
1	CXC ChemokinesIBA 01/2011
1	Cell Adhesion MoleculesIBA 01/2011
1	Tyrosine (L-Tyrosine)FDA Link 09/2009
1	Transforming Growth Factor alpha (TGF-alpha)IBA 09/2009
1	Carrier Proteins (Binding Protein)IBA 09/2009
1	Irinotecan (Camptosar)FDA LinkGeneric 06/2005
1	Thromboplastin (Tissue Factor)IBA 04/2005
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2005
1	Microfilament Proteins (Actin Binding Proteins)IBA 01/2005
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 10/2004
1	RNA (Ribonucleic Acid)IBA 07/2004
1	Decitabine FDA Link 01/2004
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2003

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2021 - 06/2020
2	Immunotherapy 06/2020 - 03/2018
1	Neoadjuvant Therapy 01/2022
1	Therapeutics 10/2017
1	Adjuvant Chemotherapy 12/2016